Studying brain blood flow in mood disorders and mild memory problems
Uses a noninvasive brain scan in adults with depression, bipolar disorder, or memory problems.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 26 Mar 2025
- Expected to end
- 30 Mar 2028
- Type of study
- Observational, 4 groups
- Treatments tested
- Observational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels.
- Record updated
- 29 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with major depressive disorder, bipolar disorder or mild cognitive impairment, and for healthy volunteers. Brain activity is measured with a safe, noninvasive scan called fNIRS.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- A confirmed diagnosis of major depressive disorder, bipolar disorder I or II, or mild cognitive impairment. The condition must be stable, with no acute episode needing immediate care. Healthy volunteers must have no past or current psychiatric or cognitive disorder.
- Earlier treatment
- People with major depressive disorder cannot join if they had brain stimulation therapy in the past 3 months.
Main reasons for not taking part
- Active primary psychotic or substance use disorder (except nicotine) in the past year
- Severe or unstable medical condition
- Active neurological condition such as seizures, brain injury or stroke
- Pregnancy
- Dementia (for the mild cognitive impairment group)
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- General Inclusion Criteria (across all diagnostic groups):
- 18 years and older
- Ability to provide written informed consent
- Adequate cognitive and language abilities to understand and complete study tasks, including clinical assessments and fNIRS procedures
- Confirmed clinical diagnosis of major depressive disorder, bipolar disorder, or mild cognitive impairment (MCI)
- Stable psychiatric or cognitive condition, without acute episodes requiring immediate intervention; Specific Inclusion Criteria (for diagnostic groups):
- Healthy control; o No past or current psychiatric or cognitive disorder
- Major depressive disorder (MDD):; Diagnosis of major depressive disorder, confirmed through clinical evaluation; No history of bipolar disorder or psychotic symptoms
- Bipolar disorder:; o Diagnosis of bipolar disorder I or II, confirmed through clinical evaluation
- Mild Cognitive Impairment (MCI):; Pre-existing clinical diagnosis of mild cognitive impairment, supported by neuropsychological testing and/or MRI, PET scan data; No history of major psychiatric disorders, such as major depression, bipolar disorder or schizophrenia
Who cannot take part
- Active primary psychotic or substance use disorders (except nicotine dependence) within the past year
- Any severe or unstable medical condition that could interfere with participation or data collection
- Any active neurological condition (including seizure disorder, traumatic brain injury, stroke) that could affect cognitive functioning or brain imaging results
- Healthy control; o Any past or current psychiatric or cognitive disorder
- Major depressive disorder (MDD):; Diagnosis of bipolar disorder or schizophrenia; Brain stimulation therapy within the past 3 months
- Bipolar disorder:; o Diagnosis of schizophrenia or schizoaffective disorder
- Mild Cognitive Impairment (MCI):; Diagnosis of dementia; Significant cognitive impairment preventing understanding or completion of study tasks
- General Exclusion Criteria (across all diagnostic groups):
- Inability to comply with study procedures, including cognitive testing, fNIRS assessment, or other assessments required by the protocol
- Pregnant women will be excluded due to potential physiological changes that could affect study outcomes; Specific Exclusion Criteria (for diagnostic groups):
Where in United States
- Mayo ClinicRochester, United StatesContact: Sarah M. WilliamsTaking people
About the trial
What the trial wants to find out
The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional near-infrared spectroscopy (fNIRS). By comparing brain activity across different groups and relating it to symptom severity, this study aims to improve our understanding of how these conditions affect the brain.
The 4 groups in the trial
- Healthy Controls
o No past or current psychiatric or cognitive disorder.
Treatment: Observational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels.
- Major Depressive Disorder
* Diagnosis of major depressive disorder, confirmed through clinical evaluation. * No history of bipolar disorder or psychotic symptoms.
Treatment: Observational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels.
- Bipolar Disorder
o Diagnosis of bipolar disorder I or II, confirmed through clinical evaluation.
Treatment: Observational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels.
- Mild Cognitive Impairment (MCI)
* Pre-existing clinical diagnosis of mild cognitive impairment, supported by neuropsychological testing and/or MRI, PET scan data. * No history of major psychiatric disorders, such as major depression, bipolar disorder or schizophrenia.
Treatment: Observational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
- Plain-language title
- Studying brain blood flow in mood disorders and mild memory problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 29 April 2026